| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,581 |
1,830 |
$597K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,649 |
2,653 |
$483K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
509 |
326 |
$155K |
| 99233 |
Prolong inpt eval add15 m |
1,416 |
954 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
927 |
642 |
$29K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
177 |
158 |
$20K |
| 80050 |
General health panel |
637 |
440 |
$17K |
| 36415 |
Collection of venous blood by venipuncture |
7,678 |
5,286 |
$15K |
| 80053 |
Comprehensive metabolic panel |
1,358 |
1,046 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,323 |
1,017 |
$8K |
| 80061 |
Lipid panel |
605 |
506 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
103 |
88 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
416 |
287 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
227 |
210 |
$4K |
| 0001A |
|
178 |
115 |
$3K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
176 |
111 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
79 |
66 |
$2K |
| 0002A |
|
107 |
71 |
$2K |
| 70450 |
Computed tomography, head or brain; without contrast material |
59 |
43 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
28 |
28 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
260 |
237 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
287 |
207 |
$2K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
45 |
42 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
112 |
77 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
28 |
17 |
$1K |
| 99307 |
|
256 |
229 |
$1K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
359 |
332 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
120 |
76 |
$1K |
| 99223 |
Prolong inpt eval add15 m |
14 |
13 |
$1K |
| 99222 |
Initial hospital care, per day, moderate complexity |
13 |
13 |
$887.67 |
| 84481 |
|
52 |
44 |
$577.49 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
50 |
35 |
$569.96 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
13 |
12 |
$399.78 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
14 |
14 |
$398.91 |
| 84439 |
|
55 |
44 |
$387.86 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
15 |
14 |
$245.49 |
| 84703 |
|
48 |
36 |
$210.56 |
| 71045 |
Radiologic examination, chest; single view |
79 |
56 |
$190.74 |
| 81001 |
|
17 |
15 |
$38.04 |
| 99310 |
Prolong nursin fac eval 15m |
12 |
12 |
$0.00 |
| T1015 |
Clinic visit/encounter, all-inclusive |
215 |
84 |
$0.00 |
| 91300 |
|
214 |
151 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
38 |
38 |
$0.00 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
14 |
13 |
$0.00 |